Testing penicillin allergy labels in blood cancer patients
Part of Blood & lymphatic, Cancer clinical trials.
This trial checks whether people with blood cancers who think they are allergic to penicillin or related antibiotics can safely take these medicines again. It aims to remove incorrect allergy labels to improve treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer such as leukemia, lymphoma, or myeloma.
- You are currently in the hospital for your cancer care.
- You have a reported allergy to penicillin, cephalosporin, or carbapenem antibiotics.
- You have not had a severe skin reaction like Stevens-Johnson syndrome or toxic epidermal necrolysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if an antibiotic allergy evaluation can help improve treatment for people with blood cancers. It aims to safely remove inaccurate penicillin allergy labels, potentially allowing use of better antibiotics.
This study tests if people with a low-risk penicillin allergy can safely have the allergy label removed through a simple risk assessment and testing, without needing a full drug challenge. It aims to help more people get the right antibiotics when needed.
This trial tests a way to safely remove 'penicillin allergy' from your medical records if you have a low-risk history. The goal is to make allergy testing more efficient and free up healthcare resources.
This trial tests a tool to help doctors safely remove a beta-lactam antibiotic allergy (like penicillin) from your medical record. If you are in the hospital and have such an allergy listed, this tool may help you get the right treatment.
This study is working to improve how doctors figure out if you are truly allergic to certain antibiotics (beta-lactams). It will test a new way to tell who is really allergic from who isn't, which could help avoid unnecessary restrictions on important medicines.
This trial compares a single dose versus two doses of a penicillin-like drug to see if people who think they are allergic to penicillin can safely be told they are not allergic. It is for people with a low-risk penicillin allergy who want to find out if they can use these antibiotics in the future.
Hear when a new Hematologic Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.